# Ursodiol-Methotrexate for Primary Biliary Cirrhosis

> **NCT00006168** · PHASE3 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)**

## Conditions studied

- Liver Cirrhosis, Biliary

## Interventions

- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT00006168
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-01
- **Primary completion:** —
- **Final completion:** 2004-03
- **Target enrollment:** — (—)
- **Last updated:** 2010-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006168, "Ursodiol-Methotrexate for Primary Biliary Cirrhosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00006168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*